Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.88 trillion, total revenue of $4.7 trillion and a weighted average PE ratio of 49.03.
Market Cap
9.88T
Revenue
4.7T
Profits
201.52B
PE Ratio
49.03
Profit Margin
4.29%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | -0.60% | 1,878,167 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 647.93B | -1.48% | 3,268,483 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 508.97B | -2.33% | 4,273,996 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 367.19B | -0.46% | 3,375,891 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.64B | -2.37% | 3,391,768 | 450.06B |
| 6 | NVS | Novartis AG | 307.77B | 0.35% | 1,003,490 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 289.84B | -0.08% | 1,490,139 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 253.65B | -1.78% | 838,152 | 47.35B |
| 9 | AMGN | Amgen Inc. | 252.03B | 0.03% | 1,694,880 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 211.44B | -0.12% | 4,038,730 | 30.99B |
| 11 | ABT | Abbott Laboratories | 190.43B | 3.63% | 3,870,073 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.54B | 1.75% | 6,290,799 | 50.34B |
| 13 | PFE | Pfizer Inc. | 175.21B | 0.72% | 20,274,036 | 63.70B |
| 14 | DHR | Danaher Corporation | 161.69B | -1.03% | 1,076,808 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.57B | 3.22% | 2,045,948 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.91B | -1.94% | 1,555,444 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.65B | -0.05% | 5,423,212 | 50.03B |
| 18 | MDT | Medtronic plc | 120.94B | 2.34% | 3,223,486 | 37.54B |
| 19 | MCK | McKesson Corporation | 117.12B | 1.00% | 302,850 | 410.98B |
| 20 | SYK | Stryker Corporation | 116.21B | 4.59% | 1,930,334 | 26.30B |
| 21 | CVS | CVS Health Corporation | 113.43B | -1.73% | 4,428,894 | 412.65B |
| 22 | SNY | Sanofi | 108.93B | 2.12% | 5,525,180 | 57.89B |
| 23 | HCA | HCA Healthcare, Inc. | 97.48B | -1.38% | 724,020 | 78.70B |
| 24 | GSK | GSK plc | 97.21B | -0.95% | 1,598,864 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 96.75B | 3.91% | 993,477 | 16.90B |
| 26 | MRNA | Moderna, Inc. | 90.71B | 2.48% | 5,431,448 | 2.23B |
| 27 | ELV | Elevance Health, Inc. | 89.31B | -1.59% | 721,077 | 201.83B |
| 28 | CI | The Cigna Group | 78.23B | -0.73% | 550,722 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.19B | -0.29% | 1,443,570 | 29.86B |
| 30 | COR | Cencora, Inc. | 63.95B | 1.30% | 566,617 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 63.58B | 4.50% | 11,868,891 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 58.81B | 1.39% | 819,137 | 254.25B |
| 33 | ARGX | argenx SE | 55.66B | -1.26% | 129,688 | 5.92B |
| 34 | NTRA | Natera, Inc. | 55.62B | -6.87% | 1,302,973 | 2.71B |
| 35 | BDX | Becton, Dickinson and Company | 54.43B | 0.99% | 528,080 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 53.29B | 0.49% | 7,111,813 | 6.51B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 52.18B | 20.17% | 1,294,077 | 4.66B |
| 38 | VEEV | Veeva Systems Inc. | 50.62B | -0.11% | 647,268 | 3.46B |
| 39 | A | Agilent Technologies, Inc. | 48.82B | -0.97% | 760,482 | 7.37B |
| 40 | HUM | Humana Inc. | 48.68B | -2.20% | 368,685 | 145.68B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 47.59B | -2.97% | 4,803,282 | 17.32B |
| 42 | WAT | Waters Corporation | 44.44B | -2.25% | 938,770 | 4.64B |
| 43 | MDLN | Medline Inc. | 44.10B | 4.42% | 2,948,355 | 29.94B |
| 44 | IQV | IQVIA Holdings Inc. | 43.22B | -1.90% | 582,299 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 41.45B | -1.57% | 115,005 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 40.46B | -1.33% | 510,187 | - |
| 47 | HLN | Haleon plc | 38.93B | 1.91% | 24,003,747 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.27B | -0.92% | 1,093,805 | 2.54B |
| 49 | ALC | Alcon Inc. | 36.97B | 3.71% | 951,185 | 10.86B |
| 50 | BIIB | Biogen Inc. | 36.80B | -1.83% | 445,869 | 10.30B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 36.11B | 4.30% | 1,980,030 | 21.64B |
| 52 | ILMN | Illumina, Inc. | 34.63B | -2.95% | 1,586,296 | 4.54B |
| 53 | ZTS | Zoetis Inc. | 34.02B | 3.29% | 3,099,591 | 9.53B |
| 54 | GMAB | Genmab A/S | 33.95B | -2.75% | 2,243,047 | 4.13B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.63B | 0.22% | 81,649 | 4.13B |
| 56 | CNC | Centene Corporation | 32.93B | -2.82% | 1,985,791 | 180.41B |
| 57 | RMD | ResMed Inc. | 32.66B | 1.00% | 686,795 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 31.44B | 2.43% | 1,665,355 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 28.95B | -1.35% | 580,513 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 28.73B | -0.03% | 779,264 | 3.40B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.50B | -0.72% | 334,395 | 11.84B |
| 62 | PHG | Koninklijke Philips N.V. | 27.03B | 2.19% | 1,339,219 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.17B | -1.84% | 2,372,549 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 25.62B | -0.23% | 177,358 | 3.15B |
| 65 | INCY | Incyte Corporation | 24.29B | -1.00% | 421,358 | 6.01B |
| 66 | INSM | Insmed Incorporated | 24.19B | -2.05% | 1,125,106 | 1.52B |
| 67 | GH | Guardant Health, Inc. | 23.11B | -3.69% | 1,154,336 | 1.18B |
| 68 | STE | STERIS plc | 22.72B | 2.59% | 206,399 | 6.04B |
| 69 | BNTX | BioNTech SE | 22.03B | -0.54% | 205,567 | 3.03B |
| 70 | VTRS | Viatris Inc. | 21.55B | -1.44% | 2,810,987 | 14.74B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.45B | -2.92% | 2,371,611 | 5.01B |
| 72 | THC | Tenet Healthcare Corporation | 21.36B | -1.79% | 591,430 | 22.15B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.46B | 2.41% | 941,126 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.22B | -0.09% | 90,432 | 2.84B |
| 75 | EXEL | Exelixis, Inc. | 17.40B | 2.74% | 2,702,411 | 2.50B |
| 76 | RVTY | Revvity, Inc. | 17.05B | -2.70% | 1,384,323 | 2.91B |
| 77 | ASND | Ascendis Pharma A/S | 16.46B | -0.24% | 147,950 | 1.20B |
| 78 | CRL | Charles River Laboratories International, Inc. | 16.39B | -4.50% | 728,182 | 4.00B |
| 79 | ICLR | ICON Public Limited Company | 15.42B | -2.63% | 393,658 | 8.23B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.86B | 0.06% | 785,625 | 3.37B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 14.73B | 0.88% | 1,535,242 | 945.54M |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.57B | -1.96% | 1,183,228 | 1.66B |
| 83 | SOLV | Solventum Corporation | 14.40B | 4.05% | 258,838 | 8.31B |
| 84 | GKOS | Glaukos Corporation | 14.36B | 2.12% | 562,935 | 690.33M |
| 85 | TEM | Tempus AI, Inc. | 14.29B | 9.66% | 11,031,999 | 1.51B |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 14.02B | -0.04% | 412,493 | 4.60B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 13.59B | -2.45% | 1,694,607 | 15.25B |
| 88 | EHC | Encompass Health Corporation | 13.55B | 1.07% | 598,772 | 6.34B |
| 89 | PEN | Penumbra, Inc. | 12.67B | 0.75% | 227,693 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.58B | 1.31% | 1,133,806 | 6.30B |
| 91 | BAX | Baxter International Inc. | 12.34B | 3.70% | 3,721,529 | 11.61B |
| 92 | FMS | Fresenius Medical Care AG | 12.09B | 0.60% | 878,749 | 22.19B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.96B | 3.82% | 3,066,588 | 5.02B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.94B | -6.86% | 1,929,124 | - |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.70B | -0.49% | 669,563 | 3.44B |
| 96 | COO | The Cooper Companies, Inc. | 11.68B | 3.12% | 906,577 | 4.24B |
| 97 | DVA | DaVita Inc. | 11.44B | -3.06% | 362,212 | 14.17B |
| 98 | TECH | Bio-Techne Corporation | 11.40B | 0.01% | 1,186,589 | 1.22B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.26B | -0.58% | 938,450 | 3.41B |
| 100 | RGEN | Repligen Corporation | 11.08B | -2.01% | 827,112 | 805.61M |
| 101 | KYMR | Kymera Therapeutics, Inc. | 10.90B | 0.80% | 604,162 | 102.24M |
| 102 | ALGN | Align Technology, Inc. | 10.89B | 2.28% | 365,452 | 4.16B |
| 103 | GMED | Globus Medical, Inc. | 10.78B | 2.91% | 707,949 | 3.14B |
| 104 | AVTR | Avantor, Inc. | 10.64B | -2.21% | 4,441,396 | 6.64B |
| 105 | MOH | Molina Healthcare, Inc. | 10.59B | -0.68% | 278,535 | 42.08B |
| 106 | PODD | Insulet Corporation | 10.59B | 2.02% | 660,225 | 3.05B |
| 107 | UHS | Universal Health Services, Inc. | 10.48B | 1.01% | 295,648 | 18.35B |
| 108 | QGEN | Qiagen N.V. | 10.41B | 0.26% | 2,117,259 | 2.10B |
| 109 | ENSG | The Ensign Group, Inc. | 10.36B | -1.32% | 163,121 | 5.67B |
| 110 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.97B | 0.31% | 219,884 | 1.28B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.89B | -0.65% | 63,680 | 2.59B |
| 112 | HSIC | Henry Schein, Inc. | 9.72B | 2.72% | 973,005 | 13.60B |
| 113 | OSCR | Oscar Health, Inc. | 9.61B | 2.60% | 1,843,861 | 15.32B |
| 114 | PCVX | Vaxcyte, Inc. | 9.55B | -2.18% | 494,347 | - |
| 115 | HNGE | Hinge Health, Inc. | 9.44B | 2.38% | 928,231 | 720.06M |
| 116 | CAI | Caris Life Sciences, Inc. | 9.22B | -5.01% | 1,464,205 | 989.61M |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 9.16B | -2.30% | 148,999 | 281.99M |
| 118 | ATR | AptarGroup, Inc. | 9.03B | 3.84% | 188,595 | 3.99B |
| 119 | SYRE | Spyre Therapeutics, Inc. | 8.88B | -1.63% | 297,219 | - |
| 120 | CORT | Corcept Therapeutics Incorporated | 8.74B | -0.35% | 686,443 | 830.81M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.73B | -0.27% | 624,753 | 67.67M |
| 122 | HQY | HealthEquity, Inc. | 8.63B | 1.80% | 426,567 | 1.36B |
| 123 | TGTX | TG Therapeutics, Inc. | 8.55B | -1.47% | 1,269,007 | 799.54M |
| 124 | IBRX | ImmunityBio, Inc. | 8.55B | -2.71% | 4,987,860 | 165.79M |
| 125 | BRKR | Bruker Corporation | 8.55B | -1.70% | 730,790 | 3.50B |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.43B | -0.33% | 540,654 | 669.50M |
| 127 | KRYS | Krystal Biotech, Inc. | 8.42B | -14.43% | 669,540 | 470.03M |
| 128 | TWST | Twist Bioscience Corporation | 8.29B | -13.50% | 1,614,046 | 431.80M |
| 129 | TXG | 10x Genomics, Inc. | 8.25B | -9.64% | 2,446,531 | 616.91M |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 7.71B | -3.38% | 76,137 | 7.46M |
| 131 | GRFS | Grifols, S.A. | 7.66B | 5.00% | 1,230,841 | 8.48B |
| 132 | ALKS | Alkermes plc | 7.50B | -1.41% | 576,079 | 1.67B |
| 133 | ABVX | ABIVAX Société Anonyme | 7.48B | -2.79% | 476,517 | 5.33M |
| 134 | PACS | PACS Group, Inc. | 7.24B | -4.41% | 348,748 | 5.55B |
| 135 | BLCO | Bausch + Lomb Corporation | 7.22B | 1.00% | 755,569 | 5.42B |
| 136 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.20B | -0.70% | 609,304 | 945.96M |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 7.12B | -5.02% | 1,570,934 | 3.12B |
| 138 | CHE | Chemed Corporation | 7.05B | 1.67% | 58,435 | 2.66B |
| 139 | IONS | Ionis Pharmaceuticals, Inc. | 6.96B | -3.79% | 842,352 | 874.09M |
| 140 | AXSM | Axsome Therapeutics, Inc. | 6.82B | -9.81% | 1,862,659 | 865.27M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.55B | -0.04% | 421,331 | 1.56B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.44B | 1.11% | 860,028 | 239.92M |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.28B | -2.02% | 316,810 | - |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.26B | -3.14% | 5,349,868 | 2.58B |
| 145 | BLTE | Belite Bio, Inc | 6.22B | -0.16% | 73,953 | - |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.19B | -4.10% | 120,955 | 253.83M |
| 147 | GRAL | GRAIL, Inc. | 6.06B | -5.39% | 430,377 | 165.26M |
| 148 | KOD | Kodiak Sciences Inc. | 6.00B | -3.61% | 217,015 | - |
| 149 | TFX | Teleflex Incorporated | 5.99B | 1.17% | 316,627 | 2.25B |
| 150 | DOCS | Doximity, Inc. | 5.95B | 1.97% | 611,569 | 655.57M |
| 151 | IMVT | Immunovant, Inc. | 5.95B | -1.30% | 401,830 | - |
| 152 | RDNT | RadNet, Inc. | 5.85B | 1.20% | 347,690 | 2.27B |
| 153 | MIRM | Mirum Pharmaceuticals, Inc. | 5.56B | 0.73% | 177,333 | 618.07M |
| 154 | WAY | Waystar Holding Corp. | 5.54B | 3.21% | 1,082,685 | 1.21B |
| 155 | MANE | Veradermics, Incorporated | 5.53B | -5.21% | 227,695 | - |
| 156 | HAE | Haemonetics Corporation | 5.51B | 1.25% | 203,507 | 1.35B |
| 157 | CGON | CG Oncology, Inc. | 5.50B | -4.02% | 265,154 | 6.23M |
| 158 | STVN | Stevanato Group S.p.A. | 5.42B | 2.43% | 131,483 | 1.40B |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.29B | -1.09% | 438,268 | - |
| 160 | MMED | MiniMed Group, Inc. | 5.28B | 2.68% | 2,490,504 | 3.22B |
| 161 | COGT | Cogent Biosciences, Inc. | 5.21B | -3.26% | 932,052 | - |
| 162 | SHC | Sotera Health Company | 5.14B | -0.83% | 993,243 | 1.22B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.13B | 2.43% | 546,588 | 1.16B |
| 164 | LFST | LifeStance Health Group, Inc. | 5.13B | 0.15% | 1,310,676 | 1.58B |
| 165 | BLLN | BillionToOne, Inc. | 5.12B | -4.34% | 312,378 | 397.41M |
| 166 | CON | Concentra Group Holdings Parent, Inc. | 5.11B | -0.74% | 286,305 | 2.29B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.09B | -1.58% | 524,698 | 1.61B |
| 168 | ERAS | Erasca, Inc. | 4.89B | -2.58% | 2,472,754 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.84B | -2.62% | 395,320 | 13.39M |
| 170 | HTFL | HeartFlow, Inc. | 4.81B | -6.28% | 819,657 | 212.07M |
| 171 | OPCH | Option Care Health, Inc. | 4.75B | -0.33% | 995,014 | 5.69B |
| 172 | DNTH | Dianthus Therapeutics, Inc. | 4.63B | 0.39% | 166,845 | 1.90M |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.61B | -3.00% | 1,193,689 | 591.33M |
| 174 | CDNA | CareDx, Inc. | 4.53B | -1.27% | 1,115,216 | 497.40M |
| 175 | DFTX | Definium Therapeutics, Inc. | 4.47B | -8.48% | 958,767 | - |
| 176 | LIVN | LivaNova PLC | 4.41B | 1.29% | 256,462 | 1.47B |
| 177 | ITGR | Integer Holdings Corporation | 4.31B | 0.07% | 216,563 | 1.83B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.29B | 2.66% | 1,166,388 | 1.37B |
| 179 | IRTC | iRhythm Holdings, Inc. | 4.19B | 2.94% | 408,507 | 825.34M |
| 180 | LEGN | Legend Biotech Corporation | 4.16B | -0.67% | 462,474 | 1.27B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | -2.38% | 456,200 | - |
| 182 | ICUI | ICU Medical, Inc. | 4.08B | -0.45% | 103,837 | 2.16B |
| 183 | ADPT | Adaptive Biotechnologies Corporation | 4.02B | -5.48% | 973,880 | 308.08M |
| 184 | ARQT | Arcutis Biotherapeutics, Inc. | 3.99B | -1.03% | 655,680 | 463.98M |
| 185 | NVST | Envista Holdings Corporation | 3.99B | 5.57% | 2,033,187 | 2.86B |
| 186 | VCYT | Veracyte, Inc. | 3.97B | -1.16% | 373,427 | 561.90M |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.85B | -4.36% | 1,378,313 | 10.35M |
| 188 | LQDA | Liquidia Corporation | 3.84B | -4.88% | 960,979 | 450.91M |
| 189 | PLSE | Pulse Biosciences, Inc. | 3.82B | 2.42% | 124,814 | 1.19M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.79B | -1.06% | 1,503,802 | 53.81M |
| 191 | ABCL | AbCellera Biologics Inc. | 3.67B | -7.58% | 1,787,993 | 66.17M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.66B | 1.15% | 989,397 | 7.50M |
| 193 | OGN | Organon & Co. | 3.63B | -0.07% | 822,795 | 6.10B |
| 194 | IOVA | Iovance Biotherapeutics, Inc. | 3.60B | -6.37% | 13,673,894 | 324.97M |
| 195 | ACAD | Acadia Pharmaceuticals Inc. | 3.50B | -1.31% | 395,836 | 1.14B |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.50B | -3.40% | 536,957 | -665.00K |
| 197 | IRON | Disc Medicine, Inc. | 3.48B | -2.93% | 176,292 | - |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.44B | -1.03% | 1,895,923 | - |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.37B | -3.81% | 230,166 | 148.00K |
| 200 | CELC | Celcuity Inc. | 3.30B | -2.31% | 325,496 | - |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.25B | 0.32% | 340,610 | - |
| 202 | RGC | Regencell Bioscience Holdings Limited | 3.23B | -2.98% | 40,902 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | -2.06% | 146,243 | 606.33M |
| 204 | NHC | National HealthCare Corporation | 3.17B | -1.84% | 63,584 | 1.56B |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.15B | 1.20% | 1,320,077 | - |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.13B | 0.11% | 158,392 | 890.79M |
| 207 | ATRC | AtriCure, Inc. | 3.06B | -1.83% | 537,076 | 569.62M |
| 208 | WRBY | Warby Parker Inc. | 3.04B | -0.20% | 1,693,613 | 911.61M |
| 209 | BHC | Bausch Health Companies Inc. | 3.04B | -1.10% | 2,566,337 | 11.11B |
| 210 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | -2.07% | 192,240 | 234.13M |
| 211 | SGRY | Surgery Partners, Inc. | 3.01B | -0.06% | 1,174,608 | 3.37B |
| 212 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.95% | 396,223 | 3.60M |
| 213 | AXGN | Axogen, Inc. | 2.99B | 1.26% | 703,332 | 266.93M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.87B | -0.15% | 634,750 | 2.60B |
| 215 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -4.10% | 933,087 | 701.94M |
| 216 | VRDN | Viridian Therapeutics, Inc. | 2.81B | 0.45% | 1,501,025 | 71.13M |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.79B | -0.10% | 423,388 | 3.37B |
| 218 | PRVA | Privia Health Group, Inc. | 2.71B | -1.40% | 536,985 | 2.36B |
| 219 | ZLAB | Zai Lab Limited | 2.70B | -1.40% | 187,300 | 449.61M |
| 220 | MBX | MBX Biosciences, Inc. | 2.64B | -2.04% | 146,304 | - |
| 221 | NEOG | Neogen Corporation | 2.62B | 1.35% | 902,902 | 884.00M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.59B | -4.77% | 526,368 | 156.04M |
| 223 | RCUS | Arcus Biosciences, Inc. | 2.58B | -1.51% | 426,632 | 117.00M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -1.99% | 197,693 | 1.46B |
| 225 | ADMA | ADMA Biologics, Inc. | 2.50B | -2.02% | 1,294,941 | 512.28M |
| 226 | BKD | Brookdale Senior Living Inc. | 2.49B | 0.38% | 2,476,730 | 2.93B |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | - | - | 865.11M |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.39B | -0.15% | 1,028,233 | 7.12M |
| 229 | PHVS | Pharvaris N.V. | 2.36B | 0.39% | 221,800 | - |
| 230 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | 1.18% | 188,120 | 1.10B |
| 231 | MD | Pediatrix Medical Group, Inc. | 2.35B | 3.49% | 321,233 | 1.96B |
| 232 | HCM | HUTCHMED (China) Limited | 2.33B | 1.22% | 31,308 | 549.12M |
| 233 | TMDX | TransMedics Group, Inc. | 2.33B | 1.94% | 303,197 | 668.47M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.31B | -2.69% | 2,531,156 | 2.48B |
| 235 | BHVN | Biohaven Ltd. | 2.30B | -1.36% | 782,505 | - |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.29B | -3.12% | 162,103 | 158.00K |
| 237 | ADUS | Addus HomeCare Corporation | 2.28B | -0.53% | 254,199 | 1.48B |
| 238 | RXRX | Recursion Pharmaceuticals, Inc. | 2.28B | -5.21% | 12,777,415 | 54.86M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.27B | 1.81% | 962,214 | - |
| 240 | PGNY | Progyny, Inc. | 2.26B | 0.82% | 433,638 | 1.31B |
| 241 | UFPT | UFP Technologies, Inc. | 2.24B | 1.72% | 18,268 | 631.64M |
| 242 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | -1.63% | 343,895 | 959.90M |
| 243 | IMNM | Immunome, Inc. | 2.20B | 6.43% | 1,169,411 | 4.02M |
| 244 | PRGO | Perrigo Company plc | 2.20B | 0.44% | 1,021,658 | 4.14B |
| 245 | XNCR | Xencor, Inc. | 2.19B | -1.14% | 702,701 | 104.97M |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -2.55% | 679,344 | 321.74M |
| 247 | NEO | NeoGenomics, Inc. | 2.17B | -3.45% | 608,859 | 787.75M |
| 248 | TRLV | Trulieve Cannabis Corp. | 2.17B | 9.44% | 1,071,409 | 1.14B |
| 249 | PVLA | Palvella Therapeutics, Inc. | 2.12B | 0.49% | 124,709 | - |
| 250 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | -2.54% | 987,245 | 940.61M |
| 251 | VCEL | Vericel Corporation | 2.05B | -0.35% | 226,392 | 306.30M |
| 252 | LKFT | Lakefront Biotherapeutics NV | 2.05B | -1.02% | 134,476 | 1.13B |
| 253 | ZYME | Zymeworks Inc. | 2.03B | 0.17% | 265,529 | 37.13M |
| 254 | ALMR | Alamar Biosciences, Inc. | 2.03B | -4.28% | 567,991 | 100.42M |
| 255 | FTRE | Fortrea Holdings Inc. | 1.98B | -3.80% | 571,020 | 2.67B |
| 256 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | 3.62% | 3,150,191 | 3.64B |
| 257 | SDGR | Schrödinger, Inc. | 1.95B | -3.83% | 455,417 | 259.04M |
| 258 | WGS | GeneDx Holdings Corp. | 1.94B | -5.76% | 181,528 | 454.43M |
| 259 | SEPN | Septerna, Inc. | 1.93B | -5.80% | 118,531 | 98.88M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | -4.74% | 613,450 | 208.78M |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -2.26% | 320,910 | 1.97B |
| 262 | TRVI | Trevi Therapeutics, Inc. | 1.92B | -0.52% | 465,989 | - |
| 263 | INSP | Inspire Medical Systems, Inc. | 1.92B | -2.41% | 330,644 | 898.74M |
| 264 | MESO | Mesoblast Limited | 1.92B | -2.70% | 157,614 | 120.25M |
| 265 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | -0.89% | 172,555 | - |
| 266 | PGEN | Precigen, Inc. | 1.92B | -22.84% | 10,754,295 | 85.72M |
| 267 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.24% | 440,031 | 303.23M |
| 268 | ASTH | Astrana Health, Inc. | 1.88B | 0.55% | 71,020 | 3.84B |
| 269 | LMAT | LeMaitre Vascular, Inc. | 1.87B | 0.90% | 74,357 | 262.43M |
| 270 | TRAX | First Tracks Biotherapeutics, Inc. | 1.86B | -1.79% | 186,729 | - |
| 271 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | -4.90% | 1,028,559 | 335.41M |
| 272 | ESTA | Establishment Labs Holdings Inc. | 1.85B | -0.43% | 349,694 | 264.03M |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 1.83B | 0.43% | 647,256 | 98.34M |
| 274 | ADRX | ADARx Pharmaceuticals, Inc. | 1.82B | -4.65% | 214,740 | 6.13M |
| 275 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -2.04% | 172,937 | 1.00M |
| 276 | AMN | AMN Healthcare Services, Inc. | 1.79B | -2.06% | 350,852 | 3.43B |
| 277 | KMTS | Kestra Medical Technologies, Ltd. | 1.79B | 0.99% | 114,074 | 106.73M |
| 278 | REPL | Replimune Group, Inc. | 1.79B | 6.93% | 4,140,510 | - |
| 279 | SLS | SELLAS Life Sciences Group, Inc. | 1.74B | -10.85% | 7,057,220 | - |
| 280 | GENB | Generate Biomedicines, Inc. | 1.72B | -7.19% | 431,791 | 26.48M |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.72B | 0.97% | 679,796 | 28.21M |
| 282 | HCSG | Healthcare Services Group, Inc. | 1.71B | 3.71% | 263,353 | 1.88B |
| 283 | BRVE | Braveheart Bio, Inc. | 1.71B | -2.42% | 107,267 | - |
| 284 | ABSI | Absci Corporation | 1.71B | -10.33% | 1,694,506 | 1.56M |
| 285 | PSNL | Personalis, Inc. | 1.69B | 0.16% | 792,058 | 69.67M |
| 286 | OMCL | Omnicell, Inc. | 1.68B | 0.23% | 171,578 | 1.24B |
| 287 | ARDT | Ardent Health, Inc. | 1.67B | -1.66% | 149,276 | 6.41B |
| 288 | BFLY | Butterfly Network, Inc. | 1.67B | -2.43% | 2,606,579 | 123.26M |
| 289 | URGN | UroGen Pharma Ltd. | 1.66B | 4.10% | 616,452 | 188.73M |
| 290 | CERT | Certara, Inc. | 1.66B | -1.13% | 771,520 | 421.75M |
| 291 | NTLA | Intellia Therapeutics, Inc. | 1.65B | -5.77% | 1,468,298 | 59.51M |
| 292 | NUVB | Nuvation Bio Inc. | 1.63B | -2.52% | 1,848,639 | 169.90M |
| 293 | PAHC | Phibro Animal Health Corporation | 1.63B | 3.14% | 50,574 | 1.52B |
| 294 | ALVO | Alvotech | 1.63B | -2.04% | 654,485 | 494.61M |
| 295 | QURE | uniQure N.V. | 1.62B | -5.68% | 4,906,110 | 18.67M |
| 296 | MAZE | Maze Therapeutics, Inc. | 1.62B | -4.70% | 127,115 | 20.00M |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.61B | -1.02% | 146,258 | 481.07M |
| 298 | RARE | Ultragenyx Pharmaceutical Inc. | 1.60B | 1.37% | 1,174,562 | 717.00M |
| 299 | NVAX | Novavax, Inc. | 1.60B | -3.72% | 1,925,791 | 413.80M |
| 300 | AZTA | Azenta, Inc. | 1.59B | -6.93% | 388,901 | 613.81M |
| 301 | KLRA | Kailera Therapeutics, Inc. | 1.59B | -4.59% | 266,925 | - |
| 302 | TDOC | Teladoc Health, Inc. | 1.59B | 2.35% | 3,050,387 | 2.47B |
| 303 | NVCR | NovoCure Limited | 1.55B | 1.14% | 559,017 | 725.39M |
| 304 | IMCR | Immunocore Holdings plc | 1.54B | -1.92% | 95,265 | 430.78M |
| 305 | LYCA | Lycia Therapeutics, Inc. | 1.54B | 1.02% | 107,712 | 4.44M |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | -0.52% | 174,767 | 978.38M |
| 307 | INVA | Innoviva, Inc. | 1.53B | -0.49% | 241,624 | 440.00M |
| 308 | GPCR | Structure Therapeutics Inc. | 1.48B | -4.89% | 204,020 | - |
| 309 | OCUL | Ocular Therapeutix, Inc. | 1.48B | -3.37% | 968,373 | 52.06M |
| 310 | ETON | Eton Pharmaceuticals, Inc. | 1.47B | -1.11% | 273,278 | 105.60M |
| 311 | AGL | agilon health, inc. | 1.46B | 2.66% | 84,829 | 5.92B |
| 312 | ALHC | Alignment Healthcare, Inc. | 1.46B | -3.92% | 2,850,889 | 4.94B |
| 313 | TYRA | Tyra Biosciences, Inc. | 1.46B | 0.57% | 244,965 | - |
| 314 | NBTX | Nanobiotix S.A. | 1.46B | -8.78% | 67,736 | 13.15M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.01% | 336,460 | 746.16M |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.45B | -2.36% | 730,735 | 20.00M |
| 317 | MLYS | Mineralys Therapeutics, Inc. | 1.43B | -11.11% | 2,149,996 | - |
| 318 | KRSA | Korsana Biosciences, Inc. | 1.43B | 3.95% | 63,724 | - |
| 319 | ANAB | AnaptysBio, Inc. | 1.42B | -1.53% | 92,654 | 106.09M |
| 320 | PNTG | The Pennant Group, Inc. | 1.42B | -2.66% | 158,788 | 1.10B |
| 321 | CNMD | CONMED Corporation | 1.39B | 5.46% | 175,397 | 1.37B |
| 322 | GHRS | GH Research PLC | 1.39B | -2.92% | 135,503 | - |
| 323 | DMRA | Damora Therapeutics, Inc. | 1.34B | 0.74% | 181,279 | - |
| 324 | KARD | Kardigan, Inc. | 1.31B | -1.17% | 140,253 | - |
| 325 | TNDM | Tandem Diabetes Care, Inc. | 1.30B | -1.99% | 649,765 | 1.04B |
| 326 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -3.63% | 686,542 | 5.49M |
| 327 | NUTX | Nutex Health Inc. | 1.29B | -6.03% | 116,584 | 846.72M |
| 328 | OMER | Omeros Corporation | 1.28B | -3.85% | 390,354 | 38.42M |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 0.19% | 118,259 | 804.27M |
| 330 | FRNM | Freenome, Inc. | 1.28B | -4.49% | 329,778 | 35.41M |
| 331 | NKTR | Nektar Therapeutics | 1.28B | -3.63% | 335,251 | 54.59M |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.26B | -1.27% | 272,581 | - |
| 333 | OPK | OPKO Health, Inc. | 1.26B | 1.81% | 1,683,344 | 587.90M |
| 334 | STAA | STAAR Surgical Company | 1.26B | 2.49% | 269,708 | 339.59M |
| 335 | CRON | Cronos Group Inc. | 1.25B | 2.42% | 575,436 | 179.09M |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.24B | 4.15% | 491,017 | 785.23M |
| 337 | INNV | InnovAge Holding Corp. | 1.22B | -2.99% | 198,124 | 989.71M |
| 338 | AAPG | Ascentage Pharma Group International | 1.20B | -4.33% | 1,810 | 94.61M |
| 339 | ENOV | Enovis Corporation | 1.20B | 4.72% | 996,057 | 2.30B |
| 340 | SVRA | Savara Inc. | 1.20B | -2.07% | 708,953 | - |
| 341 | CMPS | COMPASS Pathways plc | 1.20B | -25.24% | 5,147,414 | - |
| 342 | SLN | Silence Therapeutics plc | 1.19B | 0.15% | 639,702 | 615.00K |
| 343 | VOR | Vor Biopharma Inc. | 1.19B | -1.52% | 287,125 | - |
| 344 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -1.68% | 217,336 | - |
| 345 | AHG | Akso Health Group | 1.17B | 8.73% | 2,555 | 13.83M |
| 346 | VSTM | Verastem, Inc. | 1.17B | -1.03% | 888,715 | 87.53M |
| 347 | ATEC | Alphatec Holdings, Inc. | 1.17B | 6.68% | 8,691,830 | 839.72M |
| 348 | SNDX | Syndax Pharmaceuticals, Inc. | 1.16B | -4.69% | 1,235,251 | 252.25M |
| 349 | AORT | Artivion, Inc. | 1.16B | 5.29% | 215,981 | 471.47M |
| 350 | AVLN | Avalyn Pharma Inc. | 1.15B | 1.29% | 158,504 | - |
| 351 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.14B | -3.24% | 217,461 | 730.02M |
| 352 | MNKD | MannKind Corporation | 1.14B | 1.14% | 832,997 | 393.63M |
| 353 | PRCT | PROCEPT BioRobotics Corporation | 1.13B | 2.71% | 281,297 | 337.34M |
| 354 | BVS | Bioventus Inc. | 1.12B | -0.04% | 189,469 | 581.85M |
| 355 | OMDA | Omada Health, Inc. | 1.12B | -2.67% | 273,492 | 309.76M |
| 356 | SGP | SpyGlass Pharma, Inc. | 1.09B | 1.33% | 38,549 | - |
| 357 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | -1.49% | 67,920 | 1.04B |
| 358 | INBX | Inhibrx Biosciences, Inc. | 1.08B | 2.08% | 101,723 | 1.30M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.07B | 0.52% | 183,887 | 24.00M |
| 360 | IART | Integra LifeSciences Holdings Corporation | 1.07B | 8.20% | 802,123 | 1.66B |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.07B | 2.09% | 329,695 | - |
| 362 | CSTL | Castle Biosciences, Inc. | 1.07B | -5.65% | 286,257 | 357.28M |
| 363 | HROW | Harrow, Inc. | 1.07B | 1.17% | 343,285 | 275.59M |
| 364 | HSTM | HealthStream, Inc. | 1.06B | 2.91% | 146,736 | 321.12M |
| 365 | CTY | City Therapeutics, Inc. | 1.04B | 1.21% | 181,128 | 14.34M |
| 366 | CBLL | CeriBell, Inc. | 1.04B | 1.99% | 392,740 | 101.96M |
| 367 | IRMD | IRADIMED CORPORATION | 1.02B | 3.74% | 56,762 | 89.34M |
| 368 | IMTX | Immatics N.V. | 975.97M | -0.83% | 450,264 | 47.65M |
| 369 | QDEL | QuidelOrtho Corporation | 973.77M | 7.17% | 1,259,466 | 2.67B |
| 370 | MLTX | MoonLake Immunotherapeutics | 972.77M | -2.97% | 430,265 | - |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 953.74M | -1.40% | 315,203 | - |
| 372 | ORIC | ORIC Pharmaceuticals, Inc. | 950.49M | -0.76% | 471,310 | - |
| 373 | RIGL | Rigel Pharmaceuticals, Inc. | 944.27M | -1.48% | 40,741 | 276.79M |
| 374 | SIBN | SI-BONE, Inc. | 938.05M | -1.41% | 570,311 | 213.60M |
| 375 | ODTX | Odyssey Therapeutics, Inc. | 928.18M | -0.87% | 146,190 | 99.00K |
| 376 | IVA | Inventiva S.A. | 914.30M | 7.12% | 1,865,999 | 2.81M |
| 377 | PHAR | Pharming Group N.V. | 909.53M | 2.21% | 12,339 | 386.75M |
| 378 | LTGO | Latigo Biotherapeutics, Inc. | 908.30M | -1.79% | 129,499 | - |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 902.62M | -1.67% | 641,856 | 28.73M |
| 380 | MGTX | MeiraGTx Holdings plc | 892.72M | -2.05% | 198,139 | 397.50M |
| 381 | BBNX | Beta Bionics, Inc. | 879.12M | -3.46% | 345,718 | 127.27M |
| 382 | KURA | Kura Oncology, Inc. | 876.26M | -4.00% | 434,144 | 77.23M |
| 383 | JBIO | Jade Biosciences, Inc. | 875.74M | -2.06% | 321,908 | - |
| 384 | OBX | Obsidian Therapeutics, Inc. | 869.14M | -4.87% | 212,469 | - |
| 385 | GMRS | GMR Solutions Inc. | 863.49M | -0.71% | 285,340 | 5.88B |
| 386 | ANRO | Alto Neuroscience, Inc. | 860.58M | -2.96% | 194,180 | - |
| 387 | ALMS | Alumis Inc. | 825.80M | -5.20% | 618,574 | 7.40M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 819.34M | -2.89% | 218,130 | - |
| 389 | ABUS | Arbutus Biopharma Corporation | 816.12M | -2.02% | 962,650 | 181.72M |
| 390 | KIDS | OrthoPediatrics Corp. | 808.64M | 0.32% | 194,868 | 264.14M |
| 391 | AKTS | Aktis Oncology, Inc. | 796.47M | -10.11% | 352,799 | 10.06M |
| 392 | BBTX | Bambusa Therapeutics, Inc. | 790.37M | 3.50% | 190,598 | - |
| 393 | SLBT | SL Science Holding Limited | 790.05M | 15.45% | 8,379 | 3.27M |
| 394 | PHR | Phreesia, Inc. | 788.92M | 2.17% | 240,599 | 507.79M |
| 395 | AHCO | AdaptHealth Corp. | 784.45M | 1.20% | 1,056,276 | 3.36B |
| 396 | PRME | Prime Medicine, Inc. | 781.00M | -6.99% | 2,375,187 | 4.07M |
| 397 | VREX | Varex Imaging Corporation | 778.89M | 0.27% | 401,984 | 865.00M |
| 398 | INMD | InMode Ltd. | 774.55M | 1.93% | 179,094 | 374.63M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 772.54M | -0.29% | 234,323 | 808.21M |
| 400 | CTKB | Cytek Biosciences, Inc. | 753.90M | -5.38% | 618,672 | 206.71M |
| 401 | ARDX | Ardelyx, Inc. | 753.79M | -0.17% | 1,954,230 | 450.89M |
| 402 | ANNX | Annexon, Inc. | 745.05M | -2.96% | 988,862 | - |
| 403 | OABI | OmniAb, Inc. | 743.89M | -0.20% | 1,083,377 | 40.21M |
| 404 | PACB | Pacific Biosciences of California, Inc. | 735.11M | -9.21% | 5,006,319 | 159.27M |
| 405 | SANA | Sana Biotechnology, Inc. | 721.46M | -6.23% | 1,424,035 | - |
| 406 | SGMT | Sagimet Biosciences Inc. | 688.52M | -2.12% | 398,418 | - |
| 407 | ATTO | Attovia Therapeutics, Inc. | 688.42M | -0.72% | 34,122 | 1.80M |
| 408 | WVE | Wave Life Sciences, Inc. | 681.43M | -3.76% | 828,121 | 70.92M |
| 409 | AVBP | ArriVent BioPharma, Inc. | 678.47M | -7.46% | 439,774 | - |
| 410 | ACHV | Achieve Life Sciences, Inc. | 666.81M | -5.12% | 901,001 | - |
| 411 | STLN | Starling Oncology, Inc. | 652.26M | -1.99% | 702,383 | 587.24M |
| 412 | DNA | Ginkgo Bioworks Holdings, Inc. | 646.80M | -14.32% | 1,907,304 | 132.42M |
| 413 | LXRX | Lexicon Pharmaceuticals, Inc. | 640.74M | 1.41% | 889,947 | 41.47M |
| 414 | DSGN | Design Therapeutics, Inc. | 636.46M | -4.78% | 62,154 | - |
| 415 | SLDB | Solid Biosciences Inc. | 634.77M | -4.52% | 511,437 | - |
| 416 | APMD | Apnimed, Inc. | 631.12M | -7.56% | 307,513 | 115.12M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 630.34M | -4.12% | 232,286 | 92.01M |
| 418 | HELP | Helus Pharma Inc. | 629.05M | -18.74% | 2,743,456 | - |
| 419 | AURA | Aura Biosciences, Inc. | 622.23M | -2.28% | 382,979 | - |
| 420 | CADL | Candel Therapeutics, Inc. | 619.80M | -2.76% | 330,135 | - |
| 421 | NVCT | Nuvectis Pharma, Inc. | 618.40M | 2.71% | 146,184 | - |
| 422 | ANL | Adlai Nortye Group Ltd. | 616.93M | 0.31% | 114,690 | 18.06M |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 615.98M | 0.57% | 357,986 | - |
| 424 | IAM | Iambic Therapeutics, Inc. | 607.68M | -4.54% | 263,927 | 18.25M |
| 425 | SOPH | SOPHiA GENETICS SA | 606.96M | -6.55% | 197,035 | 86.17M |
| 426 | IMMX | Immix Biopharma, Inc. | 605.19M | -4.95% | 649,737 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 599.78M | -1.75% | 237,466 | 136.07M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 596.69M | -3.02% | 652,814 | 8.22M |
| 429 | GERN | Geron Corporation | 584.27M | 1.68% | 6,632,572 | 204.56M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 572.56M | -1.00% | 502,100 | 389.32M |
| 431 | CLYM | Climb Bio, Inc. | 570.34M | -3.12% | 667,115 | - |
| 432 | DBVT | DBV Technologies S.A. | 570.33M | -4.37% | 120,524 | 3.76M |
| 433 | AVR | Anteris Technologies Global Corp. | 568.39M | -7.61% | 2,837,787 | 2.24M |
| 434 | MYGN | Myriad Genetics, Inc. | 561.94M | -7.48% | 495,147 | 806.60M |
| 435 | EVO | Evotec SE | 557.46M | - | 35,415 | 819.47M |
| 436 | CBIO | Crescent Biopharma, Inc. | 552.13M | -4.30% | 35,581 | 11.88M |
| 437 | NGNE | Neurogene Inc. | 545.31M | -1.09% | 78,225 | 925.00K |
| 438 | DRUG | Bright Minds Biosciences Inc. | 544.36M | -54.89% | 1,088,127 | - |
| 439 | BCAX | Bicara Therapeutics Inc. | 543.94M | -9.97% | 991,775 | - |
| 440 | FLGT | Fulgent Genetics, Inc. | 534.76M | -5.75% | 91,390 | 323.93M |
| 441 | ENTX | Entera Bio Ltd. | 531.33M | -4.53% | 109,258 | 42.00K |
| 442 | STTK | Shattuck Labs, Inc. | 529.42M | -5.13% | 206,876 | 1.00M |
| 443 | PBYI | Puma Biotechnology, Inc. | 524.98M | -2.59% | 158,201 | 231.24M |
| 444 | SGHT | Sight Sciences, Inc. | 521.13M | 1.50% | 73,702 | 83.38M |
| 445 | TCMD | Tactile Systems Technology, Inc. | 520.10M | -0.35% | 94,602 | 350.31M |
| 446 | NRC | NRC Health | 517.70M | 2.37% | 32,311 | 143.79M |
| 447 | EVH | Evolent Health, Inc. | 511.03M | 5.12% | 646,137 | 2.10B |
| 448 | VALN | Valneva SE | 505.14M | -2.75% | 4,298 | 163.30M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 450 | INDP | Indaptus Therapeutics, Inc. | 503.75M | 6.15% | 111,516 | - |
| 451 | MDXG | MiMedx Group, Inc. | 503.44M | -11.08% | 1,114,628 | 303.73M |
| 452 | SRZN | Surrozen, Inc. | 500.89M | -1.41% | 51,593 | 11.51M |
| 453 | DCTH | Delcath Systems, Inc. | 499.66M | 2.56% | 170,425 | 95.42M |
| 454 | ANGO | AngioDynamics, Inc. | 498.35M | -1.17% | 227,899 | 325.38M |
| 455 | FTH | Faeth Therapeutics, Inc. | 491.23M | 1.71% | 87,320 | - |
| 456 | ARVN | Arvinas, Inc. | 488.43M | -4.96% | 500,138 | 316.70M |
| 457 | DMAC | DiaMedica Therapeutics Inc. | 487.49M | -2.27% | 25,032 | - |
| 458 | OCS | Oculis Holding AG | 481.20M | -5.63% | 78,410 | 1.45M |
| 459 | EOLS | Evolus, Inc. | 480.85M | -0.95% | 343,989 | 316.49M |
| 460 | OVID | Ovid Therapeutics Inc. | 478.48M | -3.54% | 1,244,105 | 1.58M |
| 461 | CTMX | CytomX Therapeutics, Inc. | 478.29M | -6.20% | 3,639,617 | 18.30M |
| 462 | GYRE | Gyre Therapeutics, Inc. | 478.21M | -0.99% | 238,219 | 109.82M |
| 463 | SSII | SS Innovations International, Inc. | 475.92M | 1.06% | 47,229 | 52.40M |
| 464 | CERS | Cerus Corporation | 474.59M | 3.29% | 754,844 | 221.55M |
| 465 | SENS | Senseonics Holdings, Inc. | 472.69M | -5.99% | 208,377 | 48.55M |
| 466 | RGNX | REGENXBIO Inc. | 468.03M | -1.53% | 482,884 | 174.48M |
| 467 | AQST | Aquestive Therapeutics, Inc. | 465.65M | -4.63% | 1,654,926 | 54.09M |
| 468 | RCEL | AVITA Medical, Inc. | 461.12M | -4.73% | 267,284 | 75.63M |
| 469 | PHAT | Phathom Pharmaceuticals, Inc. | 461.09M | 1.13% | 1,655,766 | 274.88M |
| 470 | ETRA | Electra Therapeutics, Inc. | 455.06M | -10.49% | 182,863 | - |
| 471 | MNPR | Monopar Therapeutics Inc. | 449.31M | -4.81% | 156,952 | - |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.41M | -1.17% | 128,087 | - |
| 473 | BWAY | BrainsWay Ltd. | 443.08M | -1.14% | 20,653 | 60.70M |
| 474 | YDES | YD Bio Limited | 441.99M | 5.05% | 25,309 | 1.24M |
| 475 | TKNO | Alpha Teknova, Inc. | 440.56M | -2.99% | 271,992 | 43.70M |
| 476 | KMDA | Kamada Ltd. | 429.24M | -4.03% | 133,007 | 191.85M |
| 477 | MASS | 908 Devices Inc. | 426.15M | -8.36% | 231,447 | 60.84M |
| 478 | PRTA | Prothena Corporation plc | 425.07M | -2.24% | 198,519 | 54.53M |
| 479 | NPCE | NeuroPace, Inc. | 422.88M | 0.16% | 49,932 | 106.99M |
| 480 | CRMD | CorMedix Inc. | 421.68M | -5.00% | 1,970,913 | 462.25M |
| 481 | CAPR | Capricor Therapeutics, Inc. | 409.59M | 10.42% | 3,087,522 | 11.13M |
| 482 | CARL | Carlsmed, Inc. | 407.36M | -0.20% | 49,438 | 63.30M |
| 483 | BLSM | BlossomHill Therapeutics, Inc. | 406.85M | -6.91% | 83,164 | - |
| 484 | RLMD | Relmada Therapeutics, Inc. | 405.35M | 6.15% | 866,675 | - |
| 485 | CTEV | Claritev Corporation | 403.01M | -0.92% | 43,211 | 994.67M |
| 486 | CCCC | C4 Therapeutics, Inc. | 402.29M | -2.97% | 1,232,272 | 35.04M |
| 487 | EDIT | Editas Medicine, Inc. | 401.61M | -2.06% | 507,105 | 47.01M |
| 488 | ASMB | Assembly Biosciences, Inc. | 400.70M | -2.24% | 91,647 | 74.85M |
| 489 | RZLT | Rezolute, Inc. | 400.18M | -3.42% | 393,653 | - |
| 490 | SI | Shoulder Innovations, Inc. | 400.14M | 0.47% | 14,804 | 60.06M |
| 491 | ALT | Altimmune, Inc. | 394.87M | -0.49% | 1,154,682 | 31.00K |
| 492 | MPLT | MapLight Therapeutics, Inc. | 393.20M | -6.66% | 91,324 | - |
| 493 | SRTA | Strata Critical Medical, Inc. | 392.79M | - | 647,613 | 255.98M |
| 494 | ASPE | Aspen Neuroscience, Inc. | 391.11M | -9.67% | 122,094 | - |
| 495 | PRLD | Prelude Therapeutics Incorporated | 389.32M | -2.58% | 46,299 | 22.42M |
| 496 | AVTX | Avalo Therapeutics, Inc. | 385.60M | 0.28% | 710,028 | 59.00K |
| 497 | ZURA | Zura Bio Limited | 379.04M | -2.60% | 2,432,842 | - |
| 498 | TLRY | Tilray Brands, Inc. | 378.39M | 1.98% | 2,729,217 | 963.10M |
| 499 | AUTL | Autolus Therapeutics plc | 377.95M | -6.58% | 2,771,778 | 117.39M |
| 500 | ALLO | Allogene Therapeutics, Inc. | 374.86M | -8.05% | 5,374,952 | 4.64M |